GlucaGen

glucagon · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GlucaGen, covering 2017-03-20 to 2021-02-16. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus [Phase 3]

See pricing